BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 28396438)

  • 1. Emerging infectious diseases: A proactive approach.
    Bloom DE; Black S; Rappuoli R
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):4055-4059. PubMed ID: 28396438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing vaccines against epidemic-prone emerging infectious diseases.
    Bernasconi V; Kristiansen PA; Whelan M; Román RG; Bettis A; Yimer SA; Gurry C; Andersen SR; Yeskey D; Mandi H; Kumar A; Holst J; Clark C; Cramer JP; Røttingen JA; Hatchett R; Saville M; Norheim G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Jan; 63(1):65-73. PubMed ID: 31776599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and solutions in the development of vaccines against emerging and neglected infectious diseases.
    Maslow JN
    Hum Vaccin Immunother; 2019; 15(10):2230-2234. PubMed ID: 31644396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines for neglected, emerging and re-emerging diseases.
    Madhav A; Mehrotra T; Sinha P; Mutreja A
    Semin Immunol; 2020 Aug; 50():101423. PubMed ID: 33250352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccines for emerging pathogens: prospects for licensure.
    Williamson ED; Westlake GE
    Clin Exp Immunol; 2019 Nov; 198(2):170-183. PubMed ID: 30972733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Our Shared Vulnerability to Dangerous Pathogens.
    Gostin LO
    Med Law Rev; 2017 May; 25(2):185-199. PubMed ID: 28419346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making vaccines "on demand": a potential solution for emerging pathogens and biodefense?
    De Groot AS; Einck L; Moise L; Chambers M; Ballantyne J; Malone RW; Ardito M; Martin W
    Hum Vaccin Immunother; 2013 Sep; 9(9):1877-84. PubMed ID: 23877094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging infectious disease: An underappreciated area of strategic concern for food security.
    Brooks DR; Hoberg EP; Boeger WA; Trivellone V
    Transbound Emerg Dis; 2022 Mar; 69(2):254-267. PubMed ID: 33527632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [French research organization on emerging infectious diseases: From REACTing to ANRS emerging infectious diseases].
    Delfraissy JF
    Bull Acad Natl Med; 2023 Mar; 207(3):287-294. PubMed ID: 36691475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors contributing to the occurrence of emerging infectious diseases.
    Lashley FR
    Biol Res Nurs; 2003 Apr; 4(4):258-67. PubMed ID: 12698918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging infectious disease risk: shared drivers with environmental change.
    Machalaba CM; Karesh WB
    Rev Sci Tech; 2017 Aug; 36(2):435-444. PubMed ID: 30152473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated vaccine development against emerging infectious diseases.
    Leblanc PR; Yuan J; Brauns T; Gelfand JA; Poznansky MC
    Hum Vaccin Immunother; 2012 Jul; 8(7):1010-2. PubMed ID: 22777091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Globalization and emerging infectious diseases].
    Oshitani H
    Nihon Rinsho; 2016 Dec; 74(12):1956-1961. PubMed ID: 30550649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-disseminating vaccines for emerging infectious diseases.
    Murphy AA; Redwood AJ; Jarvis MA
    Expert Rev Vaccines; 2016; 15(1):31-9. PubMed ID: 26524478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A world wide public health problem: the principal re-emerging infectious diseases.
    De Luca D'Alessandro E; Giraldi G
    Clin Ter; 2011; 162(3):e93-8. PubMed ID: 21717041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From Pasteur to genomics: progress and challenges in infectious diseases.
    Rappuoli R
    Nat Med; 2004 Nov; 10(11):1177-85. PubMed ID: 15516917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccines and global health: In search of a sustainable model for vaccine development and delivery.
    Rappuoli R; Black S; Bloom DE
    Sci Transl Med; 2019 Jun; 11(497):. PubMed ID: 31217336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission.
    Lee VJ; Aguilera X; Heymann D; Wilder-Smith A;
    Lancet Infect Dis; 2020 Jan; 20(1):17-19. PubMed ID: 31876487
    [No Abstract]   [Full Text] [Related]  

  • 20. Assembling a global vaccine development pipeline for infectious diseases in the developing world.
    Serdobova I; Kieny MP
    Am J Public Health; 2006 Sep; 96(9):1554-9. PubMed ID: 16873743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.